Leerink Partners analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) yesterday and set a price target of $7.00.
Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday and set a price ...
“Nobody thinks it’s a home run, like every payer is going to let this happen,” says Daina Graybosch, an analyst at Leerink ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback